Addex Therapeutics Ltd. (ADXN) - Pangali rega marang bathi
Addex Therapeutics (ADXN) developments are stalling due to reagent shortages and disruptions at European centers, although drug synthesis in laboratories remains on schedule following equipment upgrades. Risks are further amplified by Asian import difficulties and patent disputes. The current metric stands at -0.30, which is clearly demonstrated by the price action shown below for this neuro-drug manufacturer.
Rincian analitis perusahaan Addex Therapeutics, Ltd. (ADXN)
- rega lan prakiraan konsensus rega:
- indikator kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Rasio Utang marang Ekuitas Addex Therapeutics|ADXN - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Addex|ADXN - Gunggung utang perusahaan|Utang marang modal buku Addex Therapeutics Ltd|ADXN - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Addex Therapeutics|Likuiditas darurat addextherapeutics.com
- rincian asil keuangan lan kelipatan valuasi:
ADXN - Bathi resik perusahaan|Penghasilan resik sing dikarepake Addex Therapeutics|ADXN - Pangali P/E|Pangali Forward P/E Addex Therapeutics Ltd.|ADXN - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Addex Therapeutics Ltd|ADXN - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Addex Therapeutics|ADXN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan addextherapeutics.com|ADXN - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Addex Therapeutics
Analisis umum perusahaan:addextherapeutics.com, ADXN
The P/E ratio determines the market value of a single unit of profit, reflecting investor expectations regarding future cash flows. By analyzing the P/E valuation profile of a company, one can identify whether an asset is overbought or possesses growth potential. The metric is calculated as the ratio of the current share price to earnings per share. For Addex Therapeutics (ADXN), this indicator is sensitive to Phase 2 clinical trial successes and patent payments. The trend of this metric confirms investment attractiveness as progress is made in the treatment of Parkinson's disease.
Pesaing wigati
Pangali P/E biogen.com|Pangali P/E NBIX|Regencell Bioscience Ltd - Pangali rega marang bathi|Pangali P/E AXSM (Axsome Therapeutics Inc)|ACAD: Pangali rega marang bathi|Xenon Pharmaceuticals - Pangali P/E|Kapitalisasi marang bathi vikingtherapeutics.com|SUPN (Supernus) - Koefisien rega marang bathi|Pangali rega marang bathi CPRX|Koefisien rega marang bathi DNLI|HRMY: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi BHVN (Biohaven Ltd.)|Rasio rega pasar marang bathi resik AMLX|Pangali P/E TRVI (Trevi Therapeutics, Inc.)|Nilai perusahaan marang bathi resik PRAX|Anavex Corp - Pangali P/E|Kapitalisasi marang bathi CeriBell EEG|prothena.com (PRTA) - Rasio rega marang bathi|Alector - Nilai perusahaan marang bathi resik|ANNX (Annexon) - Pangali P/E|Pangali P/E Omeros Corp.|Rasio rega marang bathi Neurogene Corp (NGNE)|ACIU: Kapitalisasi marang bathi resik|Pangali P/E VYGR (Voyager Therapeutics)|neumoratx.com (NMRA) - Kapitalisasi marang bathi|SCLX: Koefisien rega marang bathi|TVGN - Pangali P/E|ACOG (alphacognition.com) - Koefisien rega marang bathi|CGTX: Rasio rega pasar marang bathi resik|IKT (Inhibikase Therapeutics) - Pangali P/E|cassavasciences.com (SAVA) - Periode bali modal bisnis|Pangali P/E ASRT|Koefisien rega marang bathi coyatherapeutics.com COYA|Rasio rega marang bathi Vistagen VTGN|Periode bali modal bisnis Ovid Therapeutics Inc (OVID)|Acumen Pharmaceuticals - Pangali P/E|CRVO - Pangali P/E|ATHE: Pangali P/E|Pangali rega marang bathi CLNN|Koefisien rega marang bathi PEPG|Pangali rega marang bathi JUNS (Jupiter Neurosciences, Inc.)|Rasio rega marang bathi Relmada Therapeutics (RLMD)|annovisbio.com - Pangali rega marang bathi|Rasio rega marang bathi Grace Therapeutics GRCE|AIFF: Pangali rega marang bathi|ANEW Medical, Inc. - Pangali P/E|Kapitalisasi marang bathi NeuroSense Therapeutics|RVPH (Reviva Pharmaceuticals) - Koefisien rega marang bathi|MetaVia (MTVA) - Pangali P/E|Rasio rega marang bathi NeurAxis|HSDT: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Passage Bio, Inc. (PASG)|NEUP - Kapitalisasi marang bathi|Pangali P/E NERV (Minerva Neurosciences)|Pangali P/E athira.com ATHA|Alzamend - Pangali P/E|CYCN (Cyclerion Therapeutics) - Pangali rega marang bathi|PTIX: Pangali P/E|Pangali rega marang bathi KTTA|CRGT (Cortigent Inc) - Pangali P/E|Kapitalisasi marang bathi avenuetx.com ATXI|Koefisien rega marang bathi BCLI (BrainStorm Cell Therapeutics)|Cara Therapeutics Inc. - Pangali rega marang bathi|Chromocell Therapeutics Corporation - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik ELYM|ITCI: Koefisien rega marang bathi|longboardpharma.com - Rasio rega pasar marang bathi resik|MRNS: Pangali P/E|NKGen Biotech Inc - Nilai perusahaan marang bathi resik|NRBO (NeuroBo) - Pangali P/E|Kapitalisasi marang bathi Sage Therapeutics Inc SAGE|Rasio rega marang bathi Synaptogenix, Inc. (SNPX)|TRVN (trevena.com) - Nilai perusahaan marang bathi resik|Pangali P/E VIGL (Vigil Neuroscience, Inc.)|Pangali P/E anewmeds.com WENA|CERE - Rasio rega marang bathi
